⚡ 1-Minute Diagnostic & Risk Matrix: Fetal UPSVS
Clinical Fast Track
• Direct UV drainage to IVC, Iliac, or RA.
• Portal System: Absent / severe agenesis (CAPVS).
• Fetal Danger: Massive volume overload, cardiomegaly ($C/T > 0.35$), hydrops, high aneuploidy rate (30–40%).
• Shunt originates from DV ampulla.
• Portal System: Intact intrahepatic portal branches.
• Fetal Danger: Variable cardiac load; high aneuploidy association. Requires detailed genetic microarray.
• Direct portal branch connection to hepatic veins / IVC.
• In-Utero: Often hemodynamically well-tolerated.
• Postnatal Danger: Hyperammonemia, portopulmonary hypertension, hepatic nodules/adenomas.
Umbilical–Portal–Systemic Venous Shunt (UPSVS) is defined as an abnormal vascular communication between the umbilical vein, portal venous system, or ductus venosus with hepatic veins, systemic veins (IVC, iliac, renal, SVC), or directly to cardiac chambers (Right Atrium, Left Atrium, Coronary Sinus).
1. Normal Anatomy: The Fetal Umbilical-Portal-Ductus Axis
The single left umbilical vein (UV) enters the fetal abdomen at the cord insertion and ascends toward the liver where it connects to the Left Portal Vein (LPV). The LPV provides three anatomical branches supplying the left lobe (superior, middle, and inferior) and continues smoothly as the Portal Sinus (PS).
The Portal Sinus forms an L-shaped vascular conduit connecting the LPV to the Right Portal Vein (RPV), which bifurcates into anterior and posterior branches. From the superior aspect of this junction arises the Ductus Venosus (DV), which directs well-oxygenated placental blood through the subdiaphragmatic vestibulum into the inferior vena cava and right atrium.
2. Classification & Distinct Clinical Profiles (Achiron Spectrum)
The classification established by Achiron & Kivilevitch (2016) divides UPSVS into three major groups based on the origin of the aberrant shunt:
Type I: Umbilical–Systemic Shunt (USS / Extrahepatic ADV)
- The Umbilical Vein completely bypasses the liver parenchyma to drain directly into the Right Atrium, Inferior Vena Cava, or Iliac/Hypogastric veins.
- The Ductus Venosus is completely absent.
- Intrahepatic Portal Venous System (IHPVS): Absent or severely hypoplastic in the majority of cases (Congenital Agenesis of the Portal Venous System / CAPVS).
- Perinatal Outcome: Earliest prenatal diagnosis, lowest live birth rate, highest incidence of high-output cardiac failure, hydrops fetalis, and chromosomal aneuploidies.
Type II: Ductus Venosus–Systemic Shunt (DVSS)
- The umbilical–portal complex develops, but blood in the Ductus Venosus is diverted via a dilated, ectatic, or abnormally displaced trunk into systemic veins (e.g., vertical end-to-side anastomosis to low IVC).
- Intrahepatic Portal Venous System: Wholly intact with normal intrahepatic portal arborization.
- Perinatal Outcome: Favorable hemodynamic tolerance in utero; however, carries a significant association with chromosomal aneuploidies (mandating microarray analysis).
Type III: Portal–Systemic Shunt (PSS / Abernethy Spectrum)
Subdivided based on anatomical location:
- Type IIIa (Intrahepatic Portal-Systemic Shunt, IHPSS): Abnormal communication between a peripheral portal branch and a hepatic vein. The IHPVS is generally intact, and in-utero hemodynamics are stable.
- Type IIIb (Extrahepatic Portal-Systemic Shunt, EHPSS): Direct abnormal connection between the main portal trunk or mesenteric/splenic veins and systemic veins (IVC or renal vein). Often accompanied by hypoplasia or absence of intrahepatic portal bifurcation (Abernethy Type I).
| Shunt Class | Vessel Course & Subtypes | Intrahepatic Portal System | Hemodynamics & Heart Strain | Associated Risks & Prognosis |
|---|---|---|---|---|
|
Type I (Umbilical–Systemic / Extrahepatic ADV) |
• Type Ia: UV connects directly to IVC below diaphragm. • Type Ib: UV connects to Iliac / Hypogastric vein. • Type Ic: UV connects directly to Right Atrium (supradiaphragmatic). |
Absent in majority (CAPVS). No portal sinus or intrahepatic portal branches seen. |
Severe Preload Surge: Massive unfiltered venous return into cardiac chambers causing right heart dilatation, tricuspid regurgitation, high C/T ratio, and hydrops fetalis. |
• Lowest live birth rate. • High rate of chromosomal defects (Trisomy 21, Turner 45,X, Noonan). • High rate of structural CHD. |
|
Type II (Ductus–Systemic Shunt) |
Ductus Venosus originates normally but is either massively dilated/aneurysmal or drains aberrantly into systemic or hepatic veins. |
Completely Intact. Normal L-shaped portal branching and liver perfusion present. |
Variable; usually well compensated in-utero unless shunt velocity causes extreme venous pulsatility and turbulence. |
• Lower frequency of structural malformations. • Notable rate of aneuploidy; mandates diagnostic genetic testing. |
|
Type III (Portal–Systemic Shunts) |
• Type IIIa (Intrahepatic): Peripheral connection between portal vein branch and hepatic vein. • Type IIIb (Extrahepatic): Main portal trunk drains into IVC or renal vein (Abernethy I & II). |
• Type IIIa: Intact branching. • Type IIIb: Partial or complete absence of intrahepatic portal bifurcation. |
Usually mild in fetal life (fetal hydrops is uncommon). Hemodynamics remain stable during gestation. | • Critical Postnatal Sequelae: Neonatal cholestasis, hyperammonemia, hepatopulmonary syndrome, portopulmonary hypertension, hepatic adenomas. |
3. Clinical Workup & Postnatal Surveillance Protocols
The presence of an intact intrahepatic portal venous system (IHPVS) is the primary determinant of long-term hepatic and systemic prognosis. In fetuses diagnosed with UPSVS, prenatal and postnatal management must adhere to the following steps:
- Serial Fetal Echocardiography: Assess cardiothoracic area ratio (C/T), RV/LV dimensions, tricuspid regurgitation Vmax, and myocardial performance every 1–2 weeks to detect decompensation early.
- Comprehensive Genetic Testing: Offer amniocentesis for Chromosomal Microarray (CMA) and gene panels for Noonan syndrome / RASopathies.
- Postnatal Pediatric Hepatology & Cardiology Follow-up: In all Type III and Abernethy variants, schedule early abdominal Doppler ultrasound, liver function tests, and serum ammonia levels to prevent delayed pulmonary hypertension and encephalopathy.